Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis
Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis.
ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes
Obecabtagene autoleucel shows promising efficacy and safety in treating relapsed/refractory B-ALL, benefiting patients of all ages, including older adults.
Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes
Simplifying complex information through illustrations has consistently helped patients feel that managing type 1 diabetes is achievable.
Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer
The data revealed that only 75% of patients receive HER2-targeting therapies.
“Peter Michael, M.D. – 711299 – 06/18/2025
Clinical Investigator
Early Alert: Infusion Pump Software Issue from Baxter
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Case-Based Insights on Managing Steroid-Refractory cGVHD After Haploidentical Transplant
Gianni Scappaticci, PharmD, BCOP, outlines a personalized, evidence-based approach to managing steroid-refractory chronic graft-versus-host disease (cGVHD) in a post–haploidentical transplant…
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of…
Oligonucleotide Synthesis Market Research and Global Forecast Report 2025-2030: Therapeutic Applications Lead Oligonucleotide Market, Expanding Scope in Disease Treatment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Oligonucleotide Synthesis Market by Product ((Drugs (ASO, SiRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment),…
CMS launches prior authorization pilot for Original Medicare
The Centers for Medicare and Medicaid Services has announced a prior authorization program pilot for original Medicare.